News & Analysis on Clinical Trial Services & Contract Research And Development
Researchers have used new laboratorial techniques that allowed them for the first time to derive unlimited numbers of purified mesenchymal precursor cells from human embryonic stem cells (HESCs). The cells can be used for regenerative stem cell...
US biotechnology major Genentech has provided further detail on its plans to dramatically increase production capacity in the wake of its $408m acquisition of Biogen-Idec's Oceanside facility.
In-PharmaTechnologist.com presents a round-up of recent appointments in the pharmaceutical development and manufacturing arena.
Sud-Chemie Performance Packaging has started manufacturing a line of scented packaging products for the nutraceutical, pharmaceutical and food industries.
German pharmaceutical firm Schering is planning to close down half its production facilities in the coming years as it strives to boost profitability and growth to a level that will beat its peers in the industry, reports Phil Taylor.
Chiral Technologies, a wholly owned subsidiary of Daicel Chemical Industries, of Japan, has licensed a chromatography column technology that promises to be particularly useful for the separation of chiral drugs.
Bayer Healthcare has entered into a licence agreement with DxS and BTG in a deal that grants Bayer Diagnostics use of the companies' DNA diagnostic technology to develop pharmacogenomic assays for the $1.9 billion (€1.6 billion) nucleic acid...